Iol Chemcials And Pharmaceuticals
IOL Chemicals and Pharmaceuticals Ltd, commonly referred to as IOL Chemicals, is a prominent player in the Indian pharmaceutical and chemical industry. Headquartered in Punjab, India, the company has established a significant presence in various operational regions, focusing on the production of high-quality active pharmaceutical ingredients (APIs) and specialty chemicals. Founded in 1986, IOL Chemicals has achieved key milestones, including expansions in manufacturing capabilities and product diversification. The company is renowned for its core offerings, which include APIs for analgesics, anti-inflammatory, and anti-diabetic medications, as well as a range of specialty chemicals. IOL Chemicals distinguishes itself through its commitment to quality and innovation, positioning itself as a trusted supplier in both domestic and international markets. With a strong market presence, IOL Chemicals continues to contribute to the pharmaceutical landscape, reflecting its dedication to excellence and sustainability.
DitchCarbon Score
How does Iol Chemcials And Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Iol Chemcials And Pharmaceuticals's score of 26 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Iol Chemcials And Pharmaceuticals's reported carbon emissions
In 2023, IOL Chemicals and Pharmaceuticals reported total carbon emissions of approximately 130,808,000,000 kg CO2e, with Scope 1 emissions accounting for about 23,786,000,000 kg CO2e, Scope 2 emissions at approximately 6,134,000,000 kg CO2e, and Scope 3 emissions reaching about 100,887,000,000 kg CO2e. This marked a significant increase from 2022, where total emissions were about 26,879,000 kg CO2e, with Scope 1 emissions at approximately 24,928,000 kg CO2e, Scope 2 at about 1,171,000 kg CO2e, and Scope 3 at around 779,000 kg CO2e. IOL Chemicals and Pharmaceuticals has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its value chain by FY2050. The company has established near-term targets to reduce absolute Scope 1 and 2 GHG emissions by 58.8% by FY2033, using FY2022 as the baseline. Additionally, it aims to cut absolute Scope 3 GHG emissions by 35% within the same timeframe. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions and Scope 3 emissions by FY2050, also based on FY2022 levels. These commitments align with industry standards and reflect a proactive approach to addressing climate change, demonstrating IOL Chemicals and Pharmaceuticals' dedication to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 24,928,000 | 00,000,000,000,000 | 00,000,000,000,000.00 |
| Scope 2 | 1,171,000 | 0,000,000,000,000 | 0,000,000,000,000 |
| Scope 3 | 779,000 | 000,000,000,000,000 | 000,000,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Iol Chemcials And Pharmaceuticals is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
